Antileishmanial activity of cryptolepine analogues and apoptotic effects of 2,7-dibromocryptolepine against Leishmania donovani promastigotes

Parasitology Research

Volumn 111, Issue 1, 2012, Pages 195-203

  Hazra, Sudipta ^a   Ghosh, Subhalakshmi ^a   Debnath, Sukalyani ^a   Seville, Scott ^b   Prajapati, Vijay Kumar ^c   Wright, Colin W ^b   Sundar, Shyam ^c   Hazra, Banasri ^a  

^a JADAVPUR UNIVERSITY   (India)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

11 AMINOCRYPTOLEPINE; 11 CHLOROCRYPTOLEPINE; 2 BROMOCRYPTOLEPINE; 2 CHLOROCRYPTOLEPINE; 2 FLUORO 7,9 DINITROCRYPTOLEPINE; 2 FLUOROCRYPTOLEPINE; 2,7 DIBROMOCRYPTOLEPINE; 5 N HYDROXYETHANEQUINDOLINE; 5 N PROPYLQUINDOLINE; 7 BROMOCRYPTOLEPINE; 8 CHLOROCRYPTOLEPINE; AMPHOTERICIN B; ANTHELMINTIC AGENT; CRYPTOLEPINE; CRYPTOLEPINE DERIVATIVE; PHOSPHATIDYLSERINE; STIBOGLUCONATE SODIUM; UNCLASSIFIED DRUG;

AMASTIGOTE; ANIMAL CELL; ANTILEISHMANIAL ACTIVITY; ANTIMALARIAL ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE PHASE; CELL MEMBRANE DEPOLARIZATION; CELL MOTILITY; CELL SURVIVAL; CELL VOLUME; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA DEGRADATION; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG INHIBITION; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; IC 50; IN VITRO STUDY; INCUBATION TIME; LEISHMANIA DONOVANI; MEMBRANE DAMAGE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROMASTIGOTE;

AFRICA, WESTERN; ALKALOIDS; ANIMALS; ANTIPROTOZOAL AGENTS; CELL SURVIVAL; CELLS, CULTURED; FEMALE; INDOLES; INHIBITORY CONCENTRATION 50; LEISHMANIA DONOVANI; MACROPHAGES; MICE; MICE, INBRED BALB C; MICROSCOPY; PLANTS, MEDICINAL; QUINOLINES;

LEISHMANIA DONOVANI; METAZOA;

EID: 84862773422     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-012-2818-9     Document Type: Article

References (24)

1. SY Ablordeppey P Fan AM Clark A Nimrod 1999 Probing the N-5 region of the indoloquinoline alkaloid, cryptolepine for anticryptoccocal activity Bioorg Med Chem 7 343 349 10218827 10.1016/S0968-0896(98)00244-2 1:CAS:528: DyaK1MXit1equ7s%3D
2. SL Croft S Sundar AH Fairlamb 2006 Drug resistance in leishmaniasis Clin Microbiol Rev 19 111 126 16418526 10.1128/CMR.19.1.111-126.2006 1:CAS:528:DC%2BD28XhsFGjtbk%3D
3. S Ghosh S Debnath S Hazra A Hartung K Thomale M Schultheis P Kapkova U Schurigt H Moll U Holzgrabe B Hazra 2011 Valeriana wallichii root extracts and fractions with activity against Leishmania spp Parasitol Res 108 861 871 21085992 10.1007/s00436-010-2127-0
4. LR Guimarães AP Rodrigues PS Marinho AH Muller GM Guilhon LS Santos JL do Nascimento EO Silva 2010 Activity of the julocrotine, a glutarimide alkaloid from Croton pullei var. glabrior, on Leishmania (L.) amazonensis Parasitol Res 107 1075 1081 20661748 10.1007/s00436-010-1973-0
5. PJ Hotez DH Molyneux A Fenwick J Kumaresan SE Sachs JD Sachs L Savioli 2007 Control of neglected tropical diseases N Engl J Med 357 1018 1027 17804846 10.1056/NEJMra064142 1:CAS:528:DC%2BD2sXhtVegsb%2FM
6. EV Kumar JR Etukala SY Ablordeppey 2008 Indolo[3,2-b]quinolines: synthesis, biological evaluation and structure activity-relationships Mini Rev Med Chem 8 538 554 18537709 10.2174/138955708784534418 1:CAS:528: DC%2BD1cXmslOiu78%3D
7. J Lavrado R Moreira A Paulo 2010 Indoloquinolines as scaffolds for drug discovery Curr Med Chem 17 2348 2370 20491639 10.2174/092986710791698521 1:CAS:528:DC%2BC3cXpsFeitbY%3D
8. JN Lisgarten M Coll J Portugal CW Wright J Aymami 2002 The antimalarial and cytotoxic drug cryptolepine intercalates into DNA at cytosine-cytosine sites Nat Struct Biol 9 57 60 11731803 10.1038/nsb729
9. R Maurya S Mehrotra VK Prajapati S Nyle'n D Sacks S Sundar 2010 Evaluation of blood agar microtiter plates for culturing Leishmania parasites to titrate parasite burden in spleen and peripheral blood of patients with visceral leishmaniasis J Clin Microbiol 48 1932 1934 20335419 10.1128/JCM.01733-09
10. F Modabber 2010 Leishmaniasis vaccines: past, present and future Int J Antimicrob Agents 36S S58 S61 10.1016/j.ijantimicag.2010.06.024
11. T Mosmann 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 65 55 63 6606682 10.1016/0022-1759(83)90303-4 1:STN:280:DyaL2c%2FovFSmtw%3D%3D
12. P Mukherjee SB Majee S Ghosh B Hazra 2009 Apoptosis-like death in Leishmania donovani promastigotes induced by diospyrin and its ethanolamine derivative Int J Antimicrob Agents 34 596 601 19783125 10.1016/j.ijantimicag. 2009.08.007 1:CAS:528:DC%2BD1MXhtlGhs7nP
13. RA Neal SL Croft 1984 An in-vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovani J Antimicrob Chemother 14 463 475 6096347 10.1093/jac/14.5.463 1:CAS:528:DyaL2MXhslSmsQ%3D%3D
14. AJ Oluwafemi EO Okanla P Camps D Munoz-Torrero ZB Mackey PK Chiang S Seville CW Wright 2009 Evaluation of cryptolepine and huperzine derivatives as lead compounds towards new agents for the treatment of human African Trypanosomiasis Nat Prod Commun 4 193 198 19370921 1:CAS:528: DC%2BD1MXit1Whs7c%3D
15. O Onyeibor SL Croft HI Dodson M Feiz-Haddad H Kendrick NJ Millington S Parapini RM Phillips S Seville SD Shnyder D Taramelli CW Wright 2005 Synthesis of some cryptolepine analogues, assessment of their antimalarial and cytotoxic activities and consideration of their antimalarial mode of action J Med Chem 48 2701 2709 15801861 10.1021/jm040893w 1:CAS:528:DC%2BD2MXhvVSisbo%3D
16. FJ Perez-Victoria MP Sanchez-Canete K Seifert SL Croft S Sundar S Castanys F Gamarro 2006 Mechanisms of experimental resistance of Leishmania to miltefosine: implications for clinical use Drug Resist Updat 9 26 39 16814199 10.1016/j.drup.2006.04.001 1:CAS:528:DC%2BD28Xmt1ylsr0%3D
17. DO Santos CE Coutinho MF Madeira CG Bottino RT Vieira SB Nascimento A Bernardino SC Bourguignon S Corte-Real RT Pinho CR Rodrigues HC Castro 2008 Leishmaniasis treatment-a challenge that remains: a review Parasitol Res 103 1 10 18389282 10.1007/s00436-008-0943-2
18. Seville S (2006) Synthesis of cryptolepine analogues as bio-reducible anticancer agents. Ph.D. thesis, University of Bradford, Bradford, UK
19. S Seville RM Phillips SD Shnyder CW Wright 2007 Synthesis of cryptolepine analogues as potential bioreducible anticancer agents Bioorg Med Chem 15 6353 6360 17643990 10.1016/j.bmc.2007.06.062 1:CAS:528:DC%2BD2sXovFOit7w%3D
20. U Sharma T Velpandian P Sharma S Singh 2009 Evaluation of anti-leishmanial activity of selected Indian plants known to have antimicrobial properties Parasitol Res 105 1287 1293 19593584 10.1007/s00436-009-1554-2
21. MN Shuaibu K Pandey PA Wuyep T Yanagi K Hirayama A Ichinose T Tanaka I Kouno 2008 Castalagin from Anogeissus leiocarpus mediates the killing of Leishmania in vitro Parasitol Res 103 1333 1338 18690475 10.1007/s00436-008- 1137-7 1:STN:280:DC%2BD1cnjslGmsA%3D%3D
22. P Srivastava VK Prajapati M Vanaerschot GVder Auwera GC Dujardin S Sundar 2010 Detection of Leptomonas sp. parasites in clinical isolates of Kala-azar patients from India Inf Gen Evol 10 1145 1150 10.1016/j.meegid.2010.07.009 1:CAS:528:DC%2BC3cXhtFajsr7O
23. WHO-TDR news item (2010) http://apps.who.int/tdr/svc/news-events/news/ ntd-elimination
24. CW Wright J Addae-Kyereme AG Breen JE Brown MF Cox SL Croft Y Gökçek H Kendrick RM Phillips PL Pollet 2001 Synthesis and evaluation of cryptolepine analogues for their potential as new antimalarial agents J Med Chem 44 3187 3194 11543688 10.1021/jm010929+ 1:CAS:528: DC%2BD3MXlvFymsr8%3D